Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.

Tafreshi NK, Bui MM, Bishop K, Lloyd MC, Enkemann SA, Lopez AS, Abrahams D, Carter BW, Vagner J, Grobmyer SR, Gillies RJ, Morse DL.

Clin Cancer Res. 2012 Jan 1;18(1):207-19. doi: 10.1158/1078-0432.CCR-11-0238. Epub 2011 Oct 20. Erratum in: Clin Cancer Res. 2012 Mar 1;18(5):1483. Gobmyer, Stephen R [corrected to Grobmyer, Stephen R].

2.

Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.

van Brussel AS, Adams A, Vermeulen JF, Oliveira S, van der Wall E, Mali WP, van Diest PJ, van Bergen En Henegouwen PM.

Breast Cancer Res Treat. 2013 Jul;140(2):263-72. doi: 10.1007/s10549-013-2635-6. Epub 2013 Jul 17.

PMID:
23860929
3.

A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes.

Tafreshi NK, Enkemann SA, Bui MM, Lloyd MC, Abrahams D, Huynh AS, Kim J, Grobmyer SR, Carter WB, Vagner J, Gillies RJ, Morse DL.

Cancer Res. 2011 Feb 1;71(3):1050-9. doi: 10.1158/0008-5472.CAN-10-3091. Epub 2010 Dec 17.

4.

The expression of stem cell protein Piwil2 and piR-932 in breast cancer.

Zhang H, Ren Y, Xu H, Pang D, Duan C, Liu C.

Surg Oncol. 2013 Dec;22(4):217-23. doi: 10.1016/j.suronc.2013.07.001. Epub 2013 Aug 27.

PMID:
23992744
5.

Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma.

Alper O, Stetler-Stevenson WG, Harris LN, Leitner WW, Ozdemirli M, Hartmann D, Raffeld M, Abu-Asab M, Byers S, Zhuang Z, Oldfield EH, Tong Y, Bergmann-Leitner E, Criss WE, Nagasaki K, Mok SC, Cramer DW, Karaveli FS, Goldbach-Mansky R, Leo P, Stromberg K, Weil RJ.

Cancer Sci. 2009 Sep;100(9):1748-56. doi: 10.1111/j.1349-7006.2009.01244.x. Epub 2009 Jun 17.

6.

Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.

Shabani N, Mylonas I, Kunert-Keil C, Briese V, Janni W, Gerber B, Friese K, Jeschke U.

Anticancer Res. 2005 May-Jun;25(3A):1761-4.

7.

Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.

Schröder CP, Ruiters MH, de Jong S, Tiebosch AT, Wesseling J, Veenstra R, de Vries J, Hoekstra HJ, de Leij LF, de Vries EG.

Int J Cancer. 2003 Sep 10;106(4):611-8.

8.

A novel biomarker C6orf106 promotes the malignant progression of breast cancer.

Jiang G, Zhang X, Zhang Y, Wang L, Fan C, Xu H, Miao Y, Wang E.

Tumour Biol. 2015 Sep;36(10):7881-9. doi: 10.1007/s13277-015-3500-5. Epub 2015 May 8.

PMID:
25953261
9.

Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.

Jeschke U, Mylonas I, Kunert-Keil C, Dazert E, Shabani N, Werling M, Kuhn C, Janni W, Gerber B, Friese K.

Oncol Rep. 2005 Mar;13(3):413-9.

PMID:
15706409
10.
11.

Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.

Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.

Anticancer Res. 2007 Jul-Aug;27(4A):1969-74.

12.

Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.

Chen CL, Chu JS, Su WC, Huang SC, Lee WY.

Virchows Arch. 2010 Jul;457(1):53-61. doi: 10.1007/s00428-010-0938-0. Epub 2010 Jun 5.

PMID:
20526721
14.
15.

Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.

Beketić-Oresković L, Sarcević B, Malenica B, Novak D.

Neoplasma. 1993;40(2):69-74.

PMID:
8394515
16.

Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases.

Verbanac KM, Min CJ, Mannie AE, Lu J, O'Brien KF, Rosman M, Tafra L; ECU/AAMC Sentinel Node Study Group.

Ann Surg Oncol. 2010 Oct;17 Suppl 3:368-77. doi: 10.1245/s10434-010-1262-2. Epub 2010 Sep 19.

PMID:
20853060
17.

MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.

Yang F, Zhou X, Miao X, Zhang T, Hang X, Tie R, Liu N, Tian F, Wang F, Yuan J.

Breast Cancer Res Treat. 2014 May;145(1):23-32. doi: 10.1007/s10549-014-2915-9. Epub 2014 Apr 1.

18.

Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.

Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H.

Int J Cancer. 1995 Feb 8;60(4):471-7.

PMID:
7530237
19.

Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9.

Petrul HM, Schatz CA, Kopitz CC, Adnane L, McCabe TJ, Trail P, Ha S, Chang YS, Voznesensky A, Ranges G, Tamburini PP.

Mol Cancer Ther. 2012 Feb;11(2):340-9. doi: 10.1158/1535-7163.MCT-11-0523. Epub 2011 Dec 6.

20.

Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.

Tafreshi NK, Lloyd MC, Proemsey JB, Bui MM, Kim J, Gillies RJ, Morse DL.

Mol Imaging Biol. 2016 Apr;18(2):219-31. doi: 10.1007/s11307-015-0885-x.

PMID:
26276155
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk